ADEDAYO AKINLOFA: Open Payments
NPI 1831622216 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 72 payments from 15 companies in 2025. Trend: 2023 $88 · 2024 $388 · 2025 $1,434
Food & beverage: $1,434
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $268 |
| Lilly USA, LLC | 11 | $215 |
| ABBVIE INC. | 11 | $180 |
| Exact Sciences Corporation | 7 | $146 |
| Amgen Inc. | 6 | $124 |
| AstraZeneca Pharmaceuticals LP | 6 | $123 |
| PFIZER INC. | 6 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Axsome Therapeutics, Inc. | 2 | $35 |
Products named: MOUNJARO, Ozempic, The Cologuard Plus Collection Kit, NURTEC ODT, Rybelsus, UBRELVY, EVENITY, FARXIGA.
Industry payments across MD — which companies pay providers there.
